DiviDrip · MENS

MENS — Jyong Biotech Ltd.

MENS is Jyong Biotech Ltd. (Healthcare) — a non-dividend-paying stock. Trading at $2.44. Market cap: $169M. Capital Quality Rank: 18/100 — Capital destroyer.

Stock snapshot

Price$2.44
Market cap$169M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)18 / 100 · Capital destroyer
Altman Z-score zoneDistress

About MENS

Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Listed2025Employees27SectorHealthcareWebsitehealtheverbiotech.com

Related non-dividend companies

Other non-dividend stocks investors research alongside MENS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is MENS's current stock price?

MENS (Jyong Biotech Ltd.) is currently trading at $2.44.

Does MENS pay a dividend?

MENS (Jyong Biotech Ltd.) does not currently pay a regular dividend.

What is MENS's Capital Quality Rank?

MENS has a Capital Quality Rank of 18/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track MENS in DiviDrip

Add MENS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow